Maternal mortality--a neglected tragedy. Where is the M in MCH?
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to D Maine.
Explore the source record for details and available documents.
This paper reports the methods and results of an innovative program of prenatal care, designed to prevent preterm delivery in Clamart, France, during 1976-1981. Rates of preterm delivery among women who entered the prenatal care program early in pregnancy (and, thus, could derive full benefit of the program) were compared with those among two comparison groups: (1) women who entered the same program later in pregnancy; and (2) women who delivered in Paris. In the first comparison, women who entered the program early had significantly lower rates of preterm delivery than did women who entered later, even when stratified by various risk factors, and when high-risk women were eliminated altogether. In the second comparison, the early care group in Clamart did not exhibit the usual inverse relationship between socioeconomic status and rates of preterm delivery. The usual significant inverse relationship was found in the Clamart population as a whole, and in the Paris series.
During 1976-1978, improvements were made in the free prenatal care provided by the maternal and child health authority (PMI) of Martinique. Central to these changes was implementation of a program of preventive prenatal care developed in France by one of the authors (EP). Data on all births during 1980-1982 show no significant difference in pregnancy outcomes between women receiving free prenatal care from the government and women receiving private care from obstetricians.
In 1978, the Food and Drug Administration denied approval of the three-month injectable contraceptive depot medroxyprogesterone acetate for use in the United States. This decision goes against the advice of the FDA's own scientific advisory panels, as well as the rulings of the World Health Organization and the drug regulation institutions of more than 70 developed and developing countries. In response to protest from the manufacturer of depot medroxyprogesterone acetate and from many health professionals, the FDA took the unusual step of scheduling a public board of inquiry to review its decision in January 1983. Reviewing the scientific literature on the risks and benefits of depot medroxyprogesterone acetate, we find no reason to deny depot medroxyprogesterone acetate approval, provided that studies of its possible side effects are continued and that women use it only after having made an informed choice between this and other methods of contraception.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Hundreds of thousands of women in developing countries die each year from complications of pregnancy, attempted abortion, and childbirth. This article presents a comprehensive and integrated framework for analyzing the cultural, social, economic, behavioral, and biological factors that influence maternal mortality. The development of a comprehensive framework was carried out by reviewing the widely accepted frameworks that have been developed for fertility and child survival, and by reviewing the existing literature on maternal mortality, including the results of research studies and accounts of intervention programs. The principal result of this exercise is the framework itself. One of the main conclusions is that all determinants of maternal mortality (and, hence, all efforts to reduce maternal mortality) must operate through a sequence of only three intermediate outcomes. These efforts must either (1) reduce the likelihood that a woman will become pregnant; (2) reduce the likelihood that a pregnant woman will experience a serious complication of pregnancy or childbirth; or (3) improve the outcomes for women with complications. Several types of interventions are most likely to have substantial and immediate effects on maternal mortality, including family planning programs to prevent pregnancies, safe abortion services to reduce the incidence of complications, and improvements in labor and delivery services to increase the survival of women who do experience complications.
Explore the source record for details and available documents.
At a recent major international workshop held in Guatemala, the state of the art of barrier contraception was examined. While there are promising leads to new methods, none is likely to be available in the near future.
Explore the source record for details and available documents.
Each year, complications related to unsafe abortion account for at least one in seven maternal deaths worldwide. Nearly all of these deaths occur in developing countries and most are preventable. The authors argue that to prevent abortion-related deaths, all women must have access to safe abortion and contraceptive services, and they discuss the strategies used to prevent abortion-related deaths--preventing unwanted pregnancy, preventing abortion, preventing unsafe abortion, and treating abortion complications. Some of these strategies have been effective, while others have failed. Preventing unwanted pregnancy is a very important starting point, but evidence suggests that it alone cannot solve the problems of abortion-related deaths. Efforts to prevent abortion, whether through legal or cultural sanctions, do not significantly reduce the number of abortions, and may even increase mortality. The technology to perform safe abortions is available, but remains underused. Finally, even under the best of circumstances, women will experience abortion complications (induced or spontaneous) and only through the prompt and effective treatment of these and other obstetric complications will deaths be averted.
In 1991, an article on the Maternity Care Program in Matlab, Bangladesh, reported a substantial decline in direct obstetric deaths in the intervention area, but not in the control area. The decline was attributed primarily to the posting of midwives at the village level. In this article, data are presented from the same period and area on a variety of intermediate events. They indicate that the decline in deaths was probably due to the combined efforts of community midwives and the physicians at the Matlab maternity clinic. Their ability to refer patients to higher levels of care was important. The data further indicate that the decline in deaths depended upon the functioning of the government hospital in Chandpur, where cesarean sections and blood transfusions were available. Midwives might also have made a special contribution by providing early termination of pregnancy, which is legal in Bangladesh.